NSAID use in first trimester may increase risk of congenital anomalies

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2006年 / 41卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：624 / +
页数：2
相关论文
共 50 条
  • [41] Fetopathological examination and congenital anomalies in the third trimester
    Carles, D
    Pelluard, F
    Alberti, EM
    Gangbo, F
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (08): : 1789 - 1799
  • [42] Selective serotonin reuptake inhibitor (SSRI) use in first trimester pregnancy and risk of congenital anomalies: a EUROmediCAT case-malformed control study in 12 countries
    Boyle, B.
    Loane, M.
    Bakker, M. K.
    Addor, M. C.
    Arriola, L.
    Garne, E.
    Gatt, M.
    Jordan, S.
    Khoshnood, B.
    Klungsoyr, K.
    Nelen, V
    Nevilie, A. J.
    O'Mahoney, M.
    Pierini, A.
    Rissmann, A.
    Tucker, D.
    Wiesel, A.
    Dolk, H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 15 - 15
  • [43] Maternal corticosteroid use and risk of selected congenital anomalies
    Carmichael, SL
    Shaw, GM
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 86 (03): : 242 - 244
  • [44] Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma
    Blais, Lucie
    Beauchesne, Marie-France
    Rey, Evelyne
    Malo, Jean-Luc
    Forget, Amelie
    [J]. THORAX, 2007, 62 (04) : 320 - 328
  • [45] First trimester exposure to buprenorphine compared to methadone for treatment of opioid use disorders and the risk of congenital malformations
    Suarez, Elizabeth A.
    Huybrechts, Krista F.
    Hernandez-Diaz, Sonia
    Straub, Loreen
    Zhu, Yanmin
    Mogun, Helen
    Bateman, Brian T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 58 - 58
  • [46] Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis
    Sun, Li
    Xi, Yang
    Wen, Xiaoke
    Zou, Wei
    [J]. PLOS ONE, 2021, 16 (09):
  • [47] Breech presentation at delivery: Do congenital anomalies of the infant increase the risk?
    Mostello, D
    Guild, C
    Stamps, K
    Leet, T
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (06) : S124 - S124
  • [48] Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy-a population cohort linkage study.
    Garne, E.
    Hansen, A., V
    Morris, J.
    Klungsoyr, K.
    Engeland, A.
    Jordan, S.
    Tucker, D.
    Thayer, D. S.
    Davies, G., I
    Andersen, Nybo A. M.
    Dolk, K. H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 16 - 16
  • [49] First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations
    Damkier, Per
    Broe, Anne
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (04): : 374 - 376
  • [50] Paroxetine use in first trimester increases risk of abnormalities
    [J]. Reactions Weekly, 2016, 1586 (1) : 12 - 12
12345